Search
Search Results
##search.searchResults.foundPlural##
-
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa
7249PDF: 3841HTML: 855 -
AGING WITH THALASSEMIA AND SICKLE CELL DISEASE: A GERONTOLOGICAL MODEL OF ACCELERATED MULTIMORBIDITY AND FUNCTION-CENTERED CARE BEYOND MIDLIFE Thalassemia and Sickle Cell Diseases: Effect of Aging
674PDF: 665Suppl. Files: 88HTML: 175 -
-
VON WILLEBRAND FACTOR, ANGIODYSPLASIA AND ANGIOGENESIS
3997PDF: 1698HTML: 8273Randi Fig: 236 -
-
PERIOPERATIVE MANAGEMENT OF SICKLE CELL DISEASE: A NARRATIVE REVIEW
10811PDF: 3397HTML: 1671 -
CURRENT ISSUES AND OPTIONS FOR HORMONAL CONTRACEPTION IN ADOLESCENTS AND YOUNG ADULT WOMEN WITH SICKLE CELL DISEASE: AN UPDATE FOR HEALTH CARE PROFESSIONALS Hormonal Contraception in Adolescents and Young Adult Women With Sickle Cell Disease
2389PDF: 1539HTML: 1008 -
SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM
2471PDF: 1114HTML: 2435 -
-
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5586PDF: 1433HTML: 2894Cover letter: 250 -
HEMATOPOIETIC STEM CELL TRANSPLANTATION IN SEVERE PEDIATRIC SICKLE CELL DISEASE: OUTCOME AND LONG-TERM COMPLICATIONS, SAUDI EXPERIENCE AT KING FAISAL SPECIALIST HOSPITAL, RIYADH, SAUDI ARABIA HCT in in Severe Pediatric Sickle Cell Disease
1480PDF: 1051HTML: 536 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
2680PDF: 895HTML: 498 -
HIV INFECTION, ANTIRETROVIRAL THERAPY AND CARDIOVASCULAR RISK
1995PDF: 867HTML: 3702 -
ON THE VERSATILITY OF VON WILLEBRAND FACTOR
3025PDF: 1256HTML: 11439 -
PREVALENCE OF SICKLE CELL TRAIT IN THE SOUTHERN SUBURBS OF BEIRUT, LEBANON
4339PDF: 1086HTML: 19285 -
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
1297PDF: 947HTML: 313 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1577PDF: 904HTML: 3154 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
4716PDF: 1585HTML: 8561 -
ACQUIRED REFRACTORY IRON DEFICIENCY
3855PDF: 1315HTML: 1645 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4840PDF: 2076HTML: 18239 -
DRUG THERAPY IN THE PROGRESSED CML PATIENT WITH MULTI-TKI FAILURE
277948PDF: 1914HTML: 3916 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4732PDF: 1833HTML: 1389 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
4498PDF: 2057HTML: 5570Table 1: 300 -
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology
1628PDF: 1039HTML: 458 -
SPLANCHNIC VEIN THROMBOSIS IN THE MEDITERRANEAN AREA IN CHILDREN
2515PDF: 1001HTML: 1724 -
ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY Endothelial biomarkers in COVID-19 recoverers one year after hospital discharge.
1470PDF: 822HTML: 429 -
CEREBRAL VENOUS THROMBOSIS IN THE MEDITERRANEAN AREA IN ADULTS
2385PDF: 850HTML: 1325







